Gianluigi Pironti1, Ryan T Strachan1, Dennis Abraham1, Samuel Mon-Wei Yu1, Minyong Chen1, Wei Chen1, Kenji Hanada1, Lan Mao1, Lewis J Watson1, Howard A Rockman2. 1. From Departments of Medicine (G.P., R.T.S., D.A., S.M.-W.Y., M.C., W.C., K.H., L.M., L.J.W., H.A.R.), Cell Biology (H.A.R.), and Molecular Genetics and Microbiology (H.A.R.), Duke University Medical Center, Durham, NC. 2. From Departments of Medicine (G.P., R.T.S., D.A., S.M.-W.Y., M.C., W.C., K.H., L.M., L.J.W., H.A.R.), Cell Biology (H.A.R.), and Molecular Genetics and Microbiology (H.A.R.), Duke University Medical Center, Durham, NC. h.rockman@duke.edu.
Abstract
BACKGROUND: Whether biomechanical force on the heart can induce exosome secretion to modulate cardiovascular function is not known. We investigated the secretion and activity of exosomes containing a key receptor in cardiovascular function, the angiotensin II type I receptor (AT1R). METHODS AND RESULTS: Exosomes containing AT1Rs were isolated from the media overlying AT1R-overexpressing cells exposed to osmotic stretch and from sera of mice undergoing cardiac pressure overload. The presence of AT1Rs in exosomes was confirmed by both electron microscopy and radioligand receptor binding assays and shown to require β-arrestin2, a multifunctional adaptor protein essential for receptor trafficking. We show that functional AT1Rs are transferred via exosomes in an in vitro model of cellular stretch. Using mice with global and cardiomyocyte conditional deletion of β-arrestin2, we show that under conditions of in vivo pressure overload the cellular source of the exocytosis of exosomes containing AT1R is the cardiomyocyte. Exogenously administered AT1R-enriched exosomes target cardiomyocytes, skeletal myocytes, and mesenteric resistance vessels and are sufficient to confer blood pressure responsiveness to angiotensin II infusion in AT1R knockout mice. CONCLUSIONS: AT1R-enriched exosomes are released from the heart under conditions of in vivo cellular stress to likely modulate vascular responses to neurohormonal stimulation. In the context of the whole organism, the concept of G protein-coupled receptor trafficking should consider circulating exosomes as part of the reservoir of functional AT1Rs.
BACKGROUND: Whether biomechanical force on the heart can induce exosome secretion to modulate cardiovascular function is not known. We investigated the secretion and activity of exosomes containing a key receptor in cardiovascular function, the angiotensin II type I receptor (AT1R). METHODS AND RESULTS: Exosomes containing AT1Rs were isolated from the media overlying AT1R-overexpressing cells exposed to osmotic stretch and from sera of mice undergoing cardiac pressure overload. The presence of AT1Rs in exosomes was confirmed by both electron microscopy and radioligand receptor binding assays and shown to require β-arrestin2, a multifunctional adaptor protein essential for receptor trafficking. We show that functional AT1Rs are transferred via exosomes in an in vitro model of cellular stretch. Using mice with global and cardiomyocyte conditional deletion of β-arrestin2, we show that under conditions of in vivo pressure overload the cellular source of the exocytosis of exosomes containing AT1R is the cardiomyocyte. Exogenously administered AT1R-enriched exosomes target cardiomyocytes, skeletal myocytes, and mesenteric resistance vessels and are sufficient to confer blood pressure responsiveness to angiotensin II infusion in AT1R knockout mice. CONCLUSIONS:AT1R-enriched exosomes are released from the heart under conditions of in vivo cellular stress to likely modulate vascular responses to neurohormonal stimulation. In the context of the whole organism, the concept of G protein-coupled receptor trafficking should consider circulating exosomes as part of the reservoir of functional AT1Rs.
Authors: Seungkirl Ahn; Christopher D Nelson; Tiffany Runyan Garrison; William E Miller; Robert J Lefkowitz Journal: Proc Natl Acad Sci U S A Date: 2003-02-11 Impact factor: 11.205
Authors: J Fauré; G Lachenal; M Court; J Hirrlinger; C Chatellard-Causse; B Blot; J Grange; G Schoehn; Y Goldberg; V Boyer; F Kirchhoff; G Raposo; J Garin; R Sadoul Journal: Mol Cell Neurosci Date: 2006-01-30 Impact factor: 4.314
Authors: Ben J C Quah; Vaughan P Barlow; Virginia McPhun; Klaus I Matthaei; Mark D Hulett; Christopher R Parish Journal: Proc Natl Acad Sci U S A Date: 2008-03-12 Impact factor: 11.205
Authors: Rebecca A Dragovic; Christopher Gardiner; Alexandra S Brooks; Dionne S Tannetta; David J P Ferguson; Patrick Hole; Bob Carr; Christopher W G Redman; Adrian L Harris; Peter J Dobson; Paul Harrison; Ian L Sargent Journal: Nanomedicine Date: 2011-05-04 Impact factor: 5.307
Authors: Amy M Booth; Yi Fang; Jonathan K Fallon; Jr-Ming Yang; James E K Hildreth; Stephen J Gould Journal: J Cell Biol Date: 2006-03-13 Impact factor: 10.539
Authors: Yun Lin; Johnathon D Anderson; Lily M A Rahnama; Shenwen V Gu; Anne A Knowlton Journal: Am J Physiol Heart Circ Physiol Date: 2020-09-28 Impact factor: 4.733
Authors: Xuan Jiang; Juliana Sucharov; Brian L Stauffer; Shelley D Miyamoto; Carmen C Sucharov Journal: Am J Physiol Heart Circ Physiol Date: 2017-01-27 Impact factor: 4.733